Your browser doesn't support javascript.
loading
Intracranial efficacy of alectinib in ALK-positive NSCLC patients with CNS metastases-a multicenter retrospective study.
Zou, Zihua; Xing, Puyuan; Hao, Xuezhi; Wang, Yan; Song, Xia; Shan, Li; Zhang, Cuiying; Liu, Ziling; Ma, Kewei; Dong, Guilan; Li, Junling.
Afiliação
  • Zou Z; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Xing P; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Hao X; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Wang Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Song X; Department of Respiratory Medicine, Shanxi Provincial Cancer Hospital, Taiyuan, People's Republic of China.
  • Shan L; Department of Thoracic oncology, Tumor Hospital Affiliated to Xinjiang Medical University, Urumqi, People's Republic of China.
  • Zhang C; Cancer center, Inner Mongolia Autonomous Region People's Hospita, Huhhot, People's Republic of China.
  • Liu Z; Cancer center, The First Hospital of Jilin University, Changchun, People's Republic of China.
  • Ma K; Cancer center, The First Hospital of Jilin University, Changchun, People's Republic of China.
  • Dong G; Department of Medical Oncology, Tangshan People's Hospital, Tangshan, People's Republic of China.
  • Li J; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China. lijunling@cicams.ac.cn.
BMC Med ; 20(1): 12, 2022 01 18.
Article em En | MEDLINE | ID: mdl-35039026
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article